(Q40658038)

English

Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes

scientific article published on May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Enhancer substances: selegiline and R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane [(-)-BPAP] enhance the neurotrophic factor synthesis on cultured mouse astrocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

based on heuristic

inferred from title

author name string

Seiichiro Shimazu

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Akie Tanigawa

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Noriyuki Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Fumio Yoneda

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Kyozo Hayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Joseph Knoll

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

72

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

2785-2792

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

The role of neuronal growth factors in neurodegenerative disorders of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

(-)1-(Benzofuran-2-yl)-2-propylaminopentane shows survival effect on cortical neurons under serum-free condition through sigma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Memories of my 45 years in research.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: rationale for prophylactic (-)deprenyl (selegiline) medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

(-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

(-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

(-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, (-)-BPAP.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Neurotrophic factors: from molecule to man.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Medial nigral dopamine neurons have rich neurotrophin support in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

The novel catecholaminergic and serotoninergic activity enhancer R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

(-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Glial cell line-derived neurotrophic factor receptor alpha1 availability regulates glial cell line-derived neurotrophic factor signaling: evidence from mice carrying one or two mutated alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

GDNF: a novel factor with therapeutic potential for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900191-7

7 January 2021

Identifiers

10.1016/S0024-3205(03)00191-7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40658038&oldid=1904254319"